
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 953 | 918 | 953 | 784 | 1058 | 1883 |
Fund Return | -4.68% | -8.21% | -4.68% | -7.81% | 1.14% | 6.53% |
Place in category | 211 | 197 | 211 | 141 | 135 | 52 |
% in Category | 83 | 77 | 83 | 68 | 69 | 45 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Pictet CH Institutional Swiss EquiZ | 1.91B | 8.90 | 2.54 | 8.57 | ||
Pictet CH Institutional Swiss EquiI | 1.91B | 6.32 | 1.38 | 6.61 | ||
Pictet CH Institutional Swiss EquiP | 1.91B | 6.27 | 1.17 | 6.39 | ||
Pictet CH Institutional Swiss EquZD | 1.91B | 6.45 | 1.86 | 7.11 | ||
Pictet CH Institutional Swiss EquID | 1.91B | 4.62 | -3.37 | 6.34 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0110869143 | 1.76B | 3.11 | -1.14 | 6.39 | ||
UBS CH Equity Fund Mid Caps Switzer | 1.35B | 6.03 | 0.20 | 7.49 | ||
Pictet CH Swiss Mid Small Cap I dy | 1.13B | -3.83 | -7.00 | 7.46 | ||
Pictet CH Swiss Mid Small Cap P dy | 1.13B | 8.34 | -1.87 | 8.92 | ||
Pictet CH Swiss Mid Small Cap Z dy | 1.13B | 7.91 | -0.92 | 9.99 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Lindt & Spruengli Part | CH0010570767 | 9.30 | 11,750.0 | +1.82% | |
Sonova H Ag | CH0012549785 | 7.16 | 231.60 | -1.28% | |
Julius Baer | CH0102484968 | 5.80 | 49.20 | -0.30% | |
Temenos Group AG | CH0012453913 | 4.93 | 61.60 | -1.60% | |
Galderma | CH1335392721 | 4.79 | 76.10 | -0.20% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review